AAV with CMV7 promoter driven hChR2(C128S/D156A)-EYFP
This AAV expresses hChR2(C128S/D156A)-EYFP driven by an ubiquitous CMV7 promoter.
The CMV7 promoter is about 0.35 kb in length and is a shortened version of the commonly used CMV promoter. CMV7 has a truncated version of the CMV enhancer. When tested in several cell lines, this promoter provides an expression level that is about 3-5 fold lower than that of the original 0.6Kb CMV promoter.
hChR2 is a humanized version of ChR2 for mammalian expression. Wild-type ChR2, as well as a few of its mutations, provides the fastest excitation of the channelrhodopsins offered, and is widely used in in optogenetics techniques in neuroscience. hChR2(D156) mutant is another SFO mutation with a 6.9-minute open-state lifetime, and hChR2(C128S/D156A) double mutation creates a Stabilized Step Function Opsin (SSFO) with a stability of the active state up to 30 minutes.
Ready-to-use AAV expressing hChR2(C128S/D156A)-EYFP driven by an ubiquitous CMV7 promoter. Available in AAV1, AAV2, AAV5, AAV6, AAV8, AAV9, AAV-DJ and other serotypes.